Male mice with reduced BDNF who received chronic cannabinoid treatment during young adulthood became hypersensitive to acute cannabinoid effects on sensory gating, with increased CB1 receptor density in the nucleus accumbens.
Read this if you are interested in how genetic vulnerability and cannabis use might interact to affect brain function.
Sex-specific effect: only male two-hit mice showed hypersensitivity to cannabinoid challenge
What the researchers found
Researchers tested a "two-hit" model for schizophrenia vulnerability: BDNF deficiency (genetic hit) combined with chronic young-adult cannabinoid exposure (environmental hit). BDNF heterozygous mice had lower baseline prepulse inhibition (PPI, a measure of sensory gating relevant to schizophrenia) and increased startle responses.
Chronic cannabinoid treatment during weeks 6-8 of life did not affect memory (Y-maze or novel object recognition) in any group. However, male BDNF-deficient mice that received chronic cannabinoid treatment showed marked PPI increases when given acute cannabinoid, while no other group showed this effect. This correlated with increased CB1 receptor density specifically in the nucleus accumbens.
Why it matters
This study models how genetic vulnerability (reduced neurotrophic support) and environmental exposure (adolescent cannabis use) might interact to alter brain function in ways relevant to schizophrenia. The sex-specific effect (males only) aligns with the higher incidence of schizophrenia in males.
The numbers in context
BDNF HET: lower baseline PPI, higher startle. Male two-hit mice (BDNF HET + chronic CP): marked PPI increase with acute CP. CB1 receptor binding increased in nucleus accumbens of male two-hit mice only. No memory effects in any group.
How the study worked
BDNF heterozygous and wild-type mice treated with CP55,940 during weeks 6-8 of life. After 2-week delay: Y-maze, novel object recognition, PPI with acute CP55,940 challenge. CB1 receptor binding autoradiography in nucleus accumbens and caudate.
What this study cannot tell us
The PPI increase with acute cannabinoid is difficult to interpret, as PPI deficits (not increases) are the typical schizophrenia-relevant measure. The CP55,940 dose and regimen may not model human cannabis use. BDNF heterozygous mice are an imperfect model of schizophrenia vulnerability. Only one brain region showed receptor changes.
How to read the evidence
Animal "two-hit" model with mixed results; preliminary evidence for gene-environment interaction.
When this study was published
Published in 2013. Gene-environment interaction models of psychosis continue to evolve.
The bigger picture
The "two-hit" hypothesis of schizophrenia proposes that genetic vulnerability combined with environmental stressors produces the disorder. This study provides partial support by showing sex-specific sensitization of sensory gating circuits, though the PPI increase (rather than decrease) was unexpected and requires interpretation.
Questions still open
- Why did the two-hit combination increase rather than decrease PPI? Does the nucleus accumbens CB1 upregulation have functional consequences beyond PPI? Would different cannabinoids or exposure windows produce different interactions with BDNF deficiency?
Common questions
Does this mean cannabis is more dangerous for people with certain genes?
What is BDNF and why does it matter?
Read the original research
An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice.
Frontiers in behavioral neuroscience, 7, 149
Citation
Klug, Maren; van den Buuse, Maarten. (2013). An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice.. Frontiers in behavioral neuroscience, 7, 149. https://doi.org/10.3389/fnbeh.2013.00149
Explore the wider topic
- How THC Affects Your Amygdala: The Brain's Threat Detector and Cannabis
- The Anandamide Connection: Your Body's Natural Bliss Molecule
- How Long for Cannabinoid Receptors to Return to Normal
- Cannabis and the Developing Brain: What Every Teenager (and Parent) Should Know
- Why Can't I Enjoy Anything Without Weed? The Science Behind It
- Dopamine Recovery After Quitting Weed: What the Science Says
- The Endocannabinoid System Explained Simply: What It Does and Why It Matters
- Your Endocannabinoid System Explained: Why Withdrawal Happens
- Your Nervous System After Quitting Weed: Fight or Flight
- Using Weed Under 18: What It Does to Your Developing Brain
- What THC Does to Your Brain: Why Withdrawal Happens
- THC and Your Prefrontal Cortex: What Cannabis Does to Your Decision-Making Brain
- Weed, Cortisol, and Stress: What Cannabis Does to Your Stress Hormones
- Weed and Memory: What the Science Says About THC and Your Hippocampus
- Weed and Motivation: Is Amotivational Syndrome Real?
- Weed and Your Nervous System: What THC Actually Does to Your Brain and Body
- How Weed Rewires Your Reward System (And How to Reset It)